期刊文献+

新型噁唑烷酮类化合物的合成及其抗凝血活性测试

Synthesis and anti-coagulant activities of new oxazolidinone
下载PDF
导出
摘要 目的合成一系列新型噁唑烷酮类化合物并考察其抗凝血活性。方法以利奈唑胺为先导化合物,采用Me-too策略,以(R)-N-{[(3-氟-4-羟基苯基)-2-氧代噁唑烷-5-基]甲基}乙酰胺1为起始原料,经过两次亲核取代反应,得到目标化合物,通过凝血时间的比较评价化合物活性。结果合成了6个噁唑烷酮类化合物,其结构经1H-NMR和MS谱确证。结论 6个化合物均有一定的抗凝血活性。 Objective To synthesize a series of oxazolidinone compounds with new structure and study their anticoagu- lant activity.Methods Taking linezolid as lead compound, the Me-too strategy was used and the starting material was (R) -N- { [ ( 3-fluorine-4-hydroxyphenyl ) -2-oxo-oxazolidin-5-yl ] methyl } acetamide 1, underwent two times of nueleophilic substitution reaction, then the target compounds were finally gained. The activities of target compounds were appraised by comparing clotting time.Results Six target compounds were synthesized and their structures were confirmed by I H-NMR and MS spectral methods,respectively.Conclusion The six oxazolidinone compounds all had considerable anti-clotting ac- tivity.
出处 《药学研究》 CAS 2016年第10期579-582,共4页 Journal of Pharmaceutical Research
基金 山西省高等学校大学生创新创业训练项目(No.2016301) 长治医学院科技创新团队支持项目(No.CX201413)
关键词 噁唑烷酮 合成 抗凝血 Oxazolidinone Synthesis Anticoagulant
  • 相关文献

参考文献7

  • 1杨娜,尤启冬.噁唑烷酮类抗菌药的研究进展[J].药学与临床研究,2011,19(4):332-336. 被引量:8
  • 2FLUIT A C,SCHMITZ F J,VERHOEF J,et al.In vitro ac- tivity of AZD2563,a novel oxazolidinone,against European Gram-positive cocci[J].J Antimicrob Chemoth- er,2002,50(2):271-276.
  • 3CHO Y L,CHAE S E,BAEK S Y,et al.Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof:WO,2010036000[P].2011-07-21.
  • 4RHEE J K,IM W B,CH0 C H,et al.Novel oxazolidinones derivatives;WO 2005058886[P].2005-06-30.
  • 5刘长令.噁唑烷酮母环的合成方法[J].精细与专用化学品,2006,14(1):6-8. 被引量:4
  • 6PERRAULT W R,PEARLMAN B A,GODREJ D B,et al.The Synthesis of N-Aryl-5( S)-aminomethyl-2-oxazo- lidinone Antibacterials and Derivatives in One Step from Aryl Carbamates [J].Org Process Res Dev,2003,7(4):533-546.
  • 7CEPANCE I,LITVIC M,MIKULDAS H,et al.Calcium trifluoromethanesulfonate-catalysed aminolysis of epoxides [J].Tetrahedron,2003,59(14):2435-2439.

二级参考文献30

  • 1[2]Fines M,Leclercq R.Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors[J].J Antimicrob Chemother,2000,45(6):797~802
  • 2[3]Eustice D C,Feldman P A,Zajac I,et al.Mechanism of action id DUP 721:inhibition of an early event during initiation of protein synthesis[J].Antimicrob Agents Chemother,1998,32:1218~1222
  • 3[5]Natesan S,Deekonda S,Manoj K K,et al.Synthesis of conformationally constrained analogues of linezolid:structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones[J].J Med Chem,2002,45(18):3953~3962
  • 4[6]Steven J B,Douglas K H,Michael R B,et al.Synthesis and antibacterial activity of U-100592 and U-100766,two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infection[J].J Med Chem,1996,39(3):673~679
  • 5[7]Bentley T J,Asato G.Anthranilonitrile derivatives and related compounds as useful agents for promotion growth,improving feed efficiency,and for increasing the lean meat to fat ratio of warm-blooded animals[P].EP 02240011 A1,1986-10-13
  • 6[8]Jacgues J,Marguet A.Selective α-bromination of an aralkyl ketone with phenyltrimethylammonium tribromide:2-bromoacetyl-6-methoxynaphthalene and 2,2-dibromoacetyl-6-methoxynaphthalene[J].Org Syn.,1976,53:111
  • 7Poulakou G, Giamarellou H. Investigational treatments for postoperative surgical site infections [J]. Expert Opin Investig Drugs, 2007, 16(2): 137-55.
  • 8Sood R, Bhadauriya T, Rao M, et al. Antimycobacterial activities of oxazolidinones: a review [J]. Infect Disord Drug Targets, 2006, 6(4): 343-54.
  • 9Howe RA, Woottonet M, Noel AR, et al. Activity of AZD2563, a novel oxazolidinone, against staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid[.l]. Antimicrob Agents Chemother, 2003, 47 (11): 3651-52.
  • 10Johnson AP. AZD-2563 AstraZeneca [J]. Curr Opin Investig Drugs, 2002, 3(6): 848-52.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部